Showing results (341-350 of 444) with videos related to

Sort By:
Pageof 45
Biorxiv : the Preprint Server for Biology|July 10, 2023
GATA1-defective immune-megakaryocytes as possible drivers of idiopathic pulmonary fibrosisFrancesca Gobbo, Maria Zingariello, Paola Verachi, et al.
The European Respiratory Journal|September 3, 2021
Nintedanib in progressive interstitial lung diseases: data from the whole INBUILD trialKevin R Flaherty, Athol U Wells, Vincent Cottin, et al.
Chest|July 25, 2025
Medical Thoracoscopy with versus without Prior Artificial Pneumothorax for Patients with Minimal or Absent Pleural EffusionKaige Wang, Liang Zhou, Min Zhu, et al.
The Lancet. Respiratory Medicine|June 21, 2014
Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validationBridget D Stuart, Joyce S Lee, Julia Kozlitina, et al.
BMJ Open Respiratory Research|September 14, 2023
Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD)Toby M Maher, Shervin Assassi, Arata Azuma, et al.
American Journal of Respiratory and Critical Care Medicine|July 14, 2026
Acute exacerbation in fibrotic interstitial lung disease: An International Working Group ReportYet H Khor, Fabrizio Luppi, Ayodeji Adegunsoye, et al.
International Journal of Molecular Sciences|February 23, 2020
Deconvolution of RNA-Seq Analysis of Hyperbaric Oxygen-Treated Mice Lungs Reveals Mesenchymal Cell Subtype ChangesYuan Yuan, Yilu Zhou, Yali Li, et al.
Chest|May 17, 2014
Fibulin-1 predicts disease progression in patients with idiopathic pulmonary fibrosisJade Jaffar, Sofia Unger, Tamera J Corte, et al.
Respiratory Research|May 21, 2022
Long-term evaluation of the safety and efficacy of recombinant human pentraxin-2 (rhPTX-2) in patients with idiopathic pulmonary fibrosis (IPF): an open-label extension studyGanesh Raghu, Mark J Hamblin, A Whitney Brown, et al.
Thorax|September 14, 2014
Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosisDaryle J DePianto, Sanjay Chandriani, Alexander R Abbas, et al.
Pageof 45